Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation

NCT06315179 is registered in ClinicalTrials.gov with Seattle Children's Hospital as lead sponsor.

NCT NCT06315179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06315179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation
Lead sponsor
Seattle Children's Hospital
Phase
Observational
Overall status
Recruiting
Start date
May 10, 2024
Completion date
January 31, 2030
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anorectal disorder, bowel dysfunction, crohn disease, esophageal diseases, functional abdominal pain syndrome, functional bowel disorder, gallbladder diseases, gastroduodenal disorder, indeterminate colitis, inflammatory bowel diseases, sphincter of oddi dysfunction, ulcerative colitis